Monica Pfeiffer, APRN
Adult Health · Overland Park, KSNPI 1770918526
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 370 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 370 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$800
- Pfizer$681
- Lilly USA, LLC$576
- AstraZeneca$525
- GSK$517
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,785100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $1,410 |
| Novo Nordisk | 41 | $800 |
| Pfizer | 42 | $681 |
| Lilly USA, LLC | 30 | $576 |
| AstraZeneca | 22 | $525 |
| GSK | 34 | $517 |
| Boston Scientific | 19 | $411 |
| Boehringer Ingelheim | 9 | $341 |
| Abbott | 11 | $206 |
| Amgen | 13 | $204 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $137 |
| Novartis | 8 | $119 |
| Amarin Pharma, Inc. | 7 | $109 |
| Idorsia Pharmaceuticals US Inc | 4 | $84 |
| Johnson & Johnson | 5 | $72 |
| Corium, LLC | 3 | $62 |
| Astellas Pharma US Inc | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $57 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Eisai Inc. | 2 | $41 |
| Abiomed | 2 | $39 |
| Merck | 3 | $38 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| IBSA Pharma Inc. | 1 | $19 |
| Gilead | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Bayer | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$222
- Wegovy$113
- AREXVY$113
- AIRSUPRA$110
- BREZTRI$110
How this compares
$6,785 in reported general payments places this provider in the 95th percentile of 155 adult health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $19,186 |
| OzempicSemaglutide | 14 | $17,631 |
| MounjaroTirzepatide | 12 | $10,989 |
| Doxycycline Monohydrate | 54 | $794 |
| Atorvastatin Calcium | 76 | $775 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $737 |
| Azelastine Hcl | 20 | $699 |
| Methylprednisolone | 95 | $574 |
| Mirtazapine | 15 | $515 |
| Levothyroxine Sodium | 50 | $502 |
| Omeprazole | 35 | $464 |
| Bupropion XlBupropion Hcl | 17 | $463 |
| Ezetimibe | 17 | $439 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $433 |
| Amlodipine Besylate | 79 | $424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $681 | $19,18618 claims |
| Novo NordiskOzempic | $800 | $17,63114 claims |
| Lilly USA, LLCMounjaro | $576 | $10,98912 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $26425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 155 adult health providers in Kansas.
Other adult health in Overland Park
- Lauren FieldsOverland Park$12K
- Tina LegaultOverland Park$12K
- Amy RiederOverland Park$6K
- Paige BudzinskiOverland Park$4K
- Mary MartinOverland Park$2K
- Carla ShepardOverland Park$2K
- Jill SoenenOverland Park$1K
- Carrie EnglertOverland Park$1K
- Debra MorrisOverland Park$1K
- Christina SchmidtOverland Park$968
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.